News and Press Releases Emmanuel Besserve 1/18/25 Emmanuel Besserve 1/18/25 Alaya.bio announces significant collaboration with leading global cancer center to advance in situ CAR-T Therapy Read More Emmanuel Besserve 10/20/23 Emmanuel Besserve 10/20/23 Alaya.bio acquires key assets from Ixaka France, accelerating the progress of its novel in vivo CAR-T immunotherapy platform Read More
Emmanuel Besserve 1/18/25 Emmanuel Besserve 1/18/25 Alaya.bio announces significant collaboration with leading global cancer center to advance in situ CAR-T Therapy Read More
Emmanuel Besserve 10/20/23 Emmanuel Besserve 10/20/23 Alaya.bio acquires key assets from Ixaka France, accelerating the progress of its novel in vivo CAR-T immunotherapy platform Read More
